Shiliang Wu
About
Shiliang Wu has authored 73 papers that have received a total of 815 indexed citations.
This includes 32 papers in Molecular Biology, 27 papers in Urology and 18 papers in Rheumatology. The topics of these papers are Glycosylation and Glycoproteins Research (24 papers), Urinary Bladder and Prostate Research (21 papers) and Galectins and Cancer Biology (16 papers). Shiliang Wu is often cited by papers focused on Glycosylation and Glycoproteins Research (24 papers), Urinary Bladder and Prostate Research (21 papers) and Galectins and Cancer Biology (16 papers) and collaborates with scholars based in China, United States and United Kingdom. Shiliang Wu's co-authors include Lan Xu, Zhi‐Hong Jiang, Li Shen, Yuke Chen and Hua Dong and has published in prestigious journals such as FEBS Letters, International Journal of Molecular Sciences and Urology.
In The Last Decade
Fields of papers published by Shiliang Wu
Since SpecializationEngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
Countries citing papers authored by Shiliang Wu
Since SpecializationCitations
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Yanju Liu Breakdown of academic impact, for papers by İpek Özkaya Breakdown of academic impact, for papers by Miloš Ajčević Breakdown of academic impact, for papers by Matthew E. Rossheim Breakdown of academic impact, for papers by Paul Clarkson Breakdown of academic impact, for papers by Robert A. Sisk Breakdown of academic impact, for papers by Tracie Harrison Breakdown of academic impact, for papers by Hongwen Li